{"id":863,"date":"2024-10-01T07:05:00","date_gmt":"2024-10-01T07:05:00","guid":{"rendered":"https:\/\/hubexostg.wpenginepowered.com\/?p=863"},"modified":"2026-02-27T08:51:39","modified_gmt":"2026-02-27T08:51:39","slug":"lars-ryding-becomes-chief-operating-officer","status":"publish","type":"post","link":"https:\/\/apac.hubexo.com\/id\/lars-ryding-becomes-chief-operating-officer\/","title":{"rendered":"Lars Ryding becomes Chief Operating Officer"},"content":{"rendered":"
\"\"<\/figure>\n\n\n\n

Lars Ryding, previously CTO Nordics, takes on a new role at Hubexo as Chief Operating Officer. 

With over 25 years of IT leadership experience in the pharmaceutical and MedTech industries, Ryding brings a proven track record of driving strategic vision, financial performance, and successful mergers and acquisitions. Previously the Group CEO and VP of Corporate Affairs at AddVision, he led global operations and stakeholder relations for one of the world\u2019s leading MedTech providers.

In his new role, Ryding will oversee Tech Delivery, Research and Technical Content, Solution Architecture, and Group IT at Hubexo, with a focus on achieving operational excellence. “I\u2019m passionate about harnessing global talent to develop state-of-the-art software solutions driven by customer insights,” Ryding said. “I look forward to combining our strengths to create impactful solutions.”<\/p>\n\n\n\n

\n

\n For more information, contact<\/span>\n \n <\/path>\n <\/path>\n <\/svg>\n <\/h3>\n

comms@hubexo.com<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Lars Ryding, previously CTO Nordics, takes on a new role at Hubexo as Chief Operating Officer.  With over 25 years of IT leadership experience in the pharmaceutical and MedTech industries, Ryding brings a proven track record of driving strategic vision, financial performance, and successful mergers and acquisitions. Previously the Group CEO and VP of Corporate […]<\/p>\n","protected":false},"author":10,"featured_media":864,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"location":[],"class_list":["post-863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"featured_image_src":"https:\/\/apac.hubexo.com\/wp-content\/uploads\/2024\/09\/Lars-newsimage.jpg","featured_image_src_square":"https:\/\/apac.hubexo.com\/wp-content\/uploads\/2024\/09\/Lars-newsimage.jpg","author_info":{"display_name":"rakamahesa","author_link":"https:\/\/apac.hubexo.com\/id\/author\/rakamahesa\/"},"_links":{"self":[{"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/posts\/863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/comments?post=863"}],"version-history":[{"count":2,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/posts\/863\/revisions"}],"predecessor-version":[{"id":5274,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/posts\/863\/revisions\/5274"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/media\/864"}],"wp:attachment":[{"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/media?parent=863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/categories?post=863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/tags?post=863"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/apac.hubexo.com\/id\/wp-json\/wp\/v2\/location?post=863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}